The effect of the β-agonist, ritodrine HCl, was studied on cardiac output (CO) and pulmonary lymph flow (Q L) in sheep. Increased CO is associated with an increase in pulmonary Q L in sheep during exercise. Isoproterenol increases CO but has not been shown to increase pulmonary Q L. Ritodrine HCl was chosen because of its association with pulmonary edema when used to halt premature labor in pregnant women. Unanesthetized sheep received an intravenous infusion of ritodrine in increasing doses over 4 h up to a maximum of 6.3 μg/kg/min. Pulmonary pressure increased 2 mmHg after 1 h and returned to baseline by hours 3 and 4 with no change in left atrial pressure or lymph to plasma protein ratio. Pulmonary Q L increased by 61% and CO by 80% at hour 3 of infusion (ritodrine dose 5.4 μg/kg/min) and remained at this level. Pulmonary Q L and CO (normalized to baseline) correlated, r = 0.72, p< 0.001, but there was no correlation between pulmonary Q L and calculated microvascular pressure. Although an increase in pulmonary microvascular endothelium permeability with concurrent pulmonary vasodilation can not be completely ruled out, it appears from this study that β-agonist theray with ritodrine increases pulmonary Q L by a CO related recruitment of microvessels.
Read full abstract